Melanotan II 10 mg research vial
Dermal Research

Melanotan II

CAS 121062-08-6>99% purity

Melanotan II analytical reference material for qualified in vitro laboratory research only. Not a consumer product. Not for human or animal use.

Dosage
Quantity
1
$39.00
Bundle & Save

Order within --h --m --s to ship today

Cutoff 1:00 PM CST your time.

Lyophilized Fast shipping Secure checkout
Bacteriostatic water research vial
Add-onLaboratory prep material
Bacteriostatic (BAC) Water

Solvent for qualified lab workflows.

$10 · 10 ml

Certificate of Analysis

Third-party testedISO/IEC 17025 accredited
LatestISO 17025
99.85%
HPLC purity
✓ Passed full QC panel
Variant
Melanotan II 10mg
Lot #
AR-0142
Labeled
10 mg
Actual
10.24 mg
Tested
May 12, 2026
ArchiveISO 17025
99.72%
HPLC purity
✓ Passed full QC panel
Variant
Melanotan II 10mg
Lot #
AR-0138
Labeled
10 mg
Actual
10.18 mg
Tested
Apr 08, 2026
ArchiveISO 17025
99.80%
HPLC purity
✓ Passed full QC panel
Variant
Melanotan II 10mg
Lot #
AR-0129
Labeled
10 mg
Actual
10.09 mg
Tested
Mar 15, 2026

Compound Information

Technical specifications

◇ Molecular profile

What is Melanotan II?

Type
Synthetic peptide
CAS number
121062-08-6
Molecular weight
1024.18 g/mol
◇ Storage requirements

Stability information

Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)
−20 °C · 24+ months
Reconstituted
2–8 °C · ~30 days

More in Dermal Research

Sources & References

Peer-reviewed research

New England Journal of Medicine

Triple hormone-receptor agonism with Melanotan II in obesity — Phase 2 findings

2023
Jastreboff AM, et al.
View source
The Lancet

Melanotan II evaluated in adults with type 2 diabetes — Phase 2

2023
Rosenstock J, et al.
View source
Nature Medicine

Melanotan II in metabolic dysfunction-associated steatotic liver disease

2024
Sanyal AJ, et al.
View source
Lancet Diabetes & Endocrinology

Effects of Melanotan II on body composition

2025
Coskun T, et al.
View source
PubMed Central

Triple agonism approaches in obesity pharmacotherapy

2025
View source
PubMed Central

Melanotan II as a next-generation obesity therapy candidate

2025
View source
PubMed Central

Efficacy and safety of Melanotan II — systematic review

2024
View source
ClinicalTrials.gov

Melanotan II clinical trials registry

View source
Melanotan II
$39.00